- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 239/54 - Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
Patent holdings for IPC class C07D 239/54
Total number of patents in this class: 502
10-year publication summary
|
42
|
37
|
33
|
33
|
39
|
39
|
52
|
28
|
30
|
7
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 19740 |
26 |
| Abbvie Inc. | 1808 |
18 |
| Corcept Therapeutics, Inc. | 284 |
16 |
| Takeda Pharmaceutical Company Limited | 2961 |
13 |
| Neurocrine Biosciences, Inc. | 381 |
13 |
| Carnegie Mellon University | 1405 |
12 |
| Bayer AG | 3045 |
9 |
| EA Pharma Co., Ltd. | 77 |
9 |
| F. Hoffmann-La Roche AG | 7958 |
8 |
| Merck Sharp & Dohme LLC | 3689 |
8 |
| Bristol-myers Squibb Company | 5080 |
7 |
| Glaxosmithkline LLC | 566 |
7 |
| Shionogi & Co., Ltd. | 914 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
7 |
| Bayer Cropscience AG | 2241 |
6 |
| Korea Research Institute of Chemical Technology | 1266 |
6 |
| E. I. du Pont de Nemours and Company | 4345 |
5 |
| Janssen Pharmaceutica N.V. | 3839 |
5 |
| Abbott Laboratories | 2542 |
5 |
| BASF AG | 1258 |
5 |
| Other owners | 310 |